chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was voicing trepidation about vaccine-was given injection. Nurse went to passenger side of car while patient continued to talk to officer who serves here. He asked officer for cool clothe. While officer was gone, patient said, "I am going to pass out" and reclined his car seat. Nurse went to patient and shouted his name, slapped his cheeks, wiped his face and arms with cool cloth, applied ice pack to face, chest, performed sternal rub-no response. Awoke alert oriented X 3.
Patient experiencing numbness in left upper arm. On and off especially when she turns her neck to her left side.
Shingles diagnosis today 6/23/2021; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 18Mar2021 at 12:00 (at the age of 47-year-old) as a single dose for COVID-19 immunization. The patient had no relevant medical history. Concomitant medications included finasteride (FINESTERIDE) and rosuvastatin calcium (ROTUVASTATIN) for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Jun2021 at 12:00, the patient experienced shingles. Shingles diagnosis the day of reporting on 23Jun2021. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles which included shingles treatment. The clinical outcome of the event shingles was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
I experienced severe gender dysphoria symptoms starting the morning after the vaccine, including uncontrollable sadness, crying and inability to be around others. I have not experienced these at anywhere near that level since June 2020. I could not shake these for several hours even though I am normally able to do so with more mild symptoms after just a few minutes which happen more frequently, multiple times per week.  I also experienced headaches and fatigue until the Tuesday following the vaccine (4 days later).
red,raised hives, itching, Shortness of breath, hoarseness, feet swollen. Pt seen in the office 24 hrs after receiving Influenza injection. Pt was given a steroid shot and given Prednisone pack.
Positive COVID-19 test on May 28, sore throat, fever, nasal congestion, headache.
ADMINISTRATION OF TWO DOSES OF JNJ VACCINE; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1816027, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021, and dose was not reported, administered on 14-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-JUN-2021, the subject experienced administration of two doses of JNJ vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of two doses of JNJ vaccine was not reported. This report was non-serious. This case, from the same reporter.
Patient states after she got the Pfizer Covid vaccine first dose, she felt some tenderness in her hands; She has been very tired; Sleeping more from it; This is a spontaneous report from a contactable physician. A 46-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021 (46-year-old) as a single dose for COVID-19 immunisation. Medical history included long qt syndrome (reported as I45.81). It was unknown if the patient had known allergies to medications, food or other products. It was unknown if the patient was diagnosed with COVID-19 prior to the vaccination. Concomitant medications included diclofenamide (KEVEYIS) taken for unspecified indication, from an unknown date and unknown if ongoing. It was unknown if the patient received any other vaccine within four weeks prior to the COVID vaccine. On an unknown date in Mar2021 after first dose of vaccination, the patient stated, she felt some tenderness in her hands and she had been very tired and sleeping more from it. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. It was unknown since the vaccination, if the patient had been tested for COVID-19. It was unknown if therapeutic measures were taken as a result of the reported events. The clinical outcome of the events she felt some tenderness in her hands, she had been very tired and sleeping more from it was unknown at the time of report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
After receiving the 2nd dose, I was extremely energetic. I was unable to sleep until around 4 AM that night. My usual sleep time is around 11 PM. I felt energetic for 2 days afterward. On the night of the third day, I was watching television (my usual routine, nothing different) when my heart began to race uncontrollably. It felt like it was beating out of my chest. My wife felt it also, and was concerned. We went to Hospital. They ran tests and found my EKG and heart health was excellent. I continued to feel like I was having a panic attack for 3 more days, when I checked myself into Hospital. They also said my EKG and heart health was excellent. I am writing this 11 days after my 2nd shot, and I still do not feel right. My heart is quick to race and at times I feel disoriented.
Approximately 10 hours after receiving this vaccine, I developed a immune response consisting of a fever and severe muscular aches. I was unable to get out of bed. By noon the next day, I was 90% recovered. It's probably important to note I received an influenza vaccine at the same time, in the same general location (Sanofi Pasteur Lot#UT6657LA). I have never had a reaction to a flu shot.
I feel very bad I have pulsatile tinnitus and pressure in my head I have been like this for 7 months.
Chest pain, shortness of breath, irregular heart rate, heart beating faster, chest pain radiating
This spontaneous report was received from a registered nurse referring to a patient of currently 1 year age and unspecified gender. The patient's pertinent medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of VARIVAX (Merck) with lot # L034368, expiry date 08-SEP-2017; dose, route of administration and anatomical location not reported). The doses of VARIVAX (Merck) underwent temperature excursion: 14.7F for 2 hours and 15 minutes. There was no previous temperature excursions. No symptoms were reported. No product quality complaint (PQC) was involved. No further information provided. This is one of several reports from the same reporter. Additional information has been requested.
Pregnant patient received Gardasil 9 on the left deltoid arm; This prospective pregnancy report was received from an office manager concerning a 34-year-old female patient. The patient has no pertinent medical history, concurrent conditions, nor drug reactions/allergies. Concomitant therapy included "multivitamins".  It was reported that the patient was pregnant. The last menstrual period (LMP) was estimated as 20-DEC-2020. On 12-AUG-2021, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), lot # T026324, 0.5 milliliter, intramuscularly (IM), in the left deltoid for prophylaxis while she was 33 weeks pregnant (vaccine exposure during pregnancy). The estimated delivery date (EDD) was reported as 11-SEP-2021. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T026324; expirationdate: 22-FEB-2023; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
itching in arm 2 Weeks after Vaccine; soreness in arm/ arm was sore for 2 days; nerve pain; This spontaneous pregnancy case was reported by a patient and describes the occurrence of PRURITUS (itching in arm 2 Weeks after Vaccine), PAIN IN EXTREMITY (soreness in arm/ arm was sore for 2 days) and NEURALGIA (nerve pain) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included LEVOTHYROXINE and METOPROLOL TARTRATE for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced PRURITUS (itching in arm 2 Weeks after Vaccine), PAIN IN EXTREMITY (soreness in arm/ arm was sore for 2 days) and NEURALGIA (nerve pain). At the time of the report, PRURITUS (itching in arm 2 Weeks after Vaccine), PAIN IN EXTREMITY (soreness in arm/ arm was sore for 2 days) and NEURALGIA (nerve pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided.
This spontaneous report was received from a physician refers to a patient of unknown age (gender unspecified). On 28-SEP-2012, the patient was vaccinated with a dose of expired PEDVAXHIB (lot # reported as 666243/1617Y, expiry 23-SEP-2012, route not reported). No concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
arm pain; really tired; really hungry; She experienced arm pain and chills after the first dose and a headache after second dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 39 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Apr2021 13:00 (Lot number: EWU175) at the age of 39 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "environmental allergies" (unspecified if ongoing). There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "arm pain"; FATIGUE (non-serious) with onset 2021, outcome "recovered" (2021), described as "really tired"; INCREASED APPETITE (non-serious) with onset 2021, outcome "recovered" (2021), described as "really hungry"; CHILLS (non-serious) with onset 2021, outcome "recovered" (2021), described as "She experienced arm pain and chills after the first dose and a headache after second dose". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The arm pain started about 5 or 6pm after getting the shot. She reports she was really tired then and the following day. Also, she was really hungry the next day too which is not normal. This all only lasted about 2 days and then went away. The caller also explains she has environmental allergies like pollen and has noticed, after the vaccines, they get severe. They have stopped but there are times she feels they more severe now when she does get them, where they were light before the vaccines.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101116701 similar report from same reporter
Information has been received from a physician concerning a 14 year old female, who, on an unspecified date, was vaccinated intramuscularly with a first dose of Gardasil.  Subsequently, the patient fainted.  The patient recovered on the same day.  The patient sought unspecified medical attention.  No product quality complaint was involved.  Additional information has been requested.
Severe migraine, body aches, nausea, gastrointestinal, sore arm, shakiness, weak, fogginess, heart palpitations, feels like ?the flu?
Bilateral visual field cuts due to separately occurring bilateral retinal emboli. The medical/ hospital records received on 2/19/04 states temporal arteritis and mitral valve mass. Records also mention coronary artery disease was established during this hospital admission. Temporal arteritis
pt recvd vax 1030AM & @ 330PM pt began screaming unconsolably for an hr; APAP administered; 45 mins later began screaming again (high pitch, piercing cry); rt thigh (HBOC site) was red; thigh to hip; seen in office; redness lasted a few hrs
Localized erythema, urticarial plaque. Measured 6 cm x 6 cm 10 days post vaccination Supportive care- cool compresses, NSAIDS, hydrocortisone
tired; hypertension; COVID vaccine / sore arm; This is a spontaneous report from a contactable consumer, based on information received by Pfizer from Eisai (manufacturer control number: EC-2021-088905), for BNT162B2.  A non-pregnant female patient (not pregnant at the time of vaccination) of an unspecified age received patient received bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: not reported, Expiry date: not reported) via an unspecified route of administration, on an unspecified date as dose number unknown, single for COVID-19 immunization and lenvatinib mesilate (LENVIMA), oral from 14May2021 (Batch/Lot Number: Unknown) and ongoing, at 4 mg, daily for ovarian cancer; ovarian cancer Lenvima 20 mg once a day with keytruda - of which on hold since 18Mar2021). The patient medical was not reported and concomitant medications included pembrolizumab (KEYTRUDA) via intravenous route for ovarian cancer which on hold since 18Mar2021. On an unspecified date in May2021, the patient experienced tired, hypertension and COVID vaccine / sore arm. It was reported that patient feel "very good" so far, except "sometimes" tired unknown onset; however, she can function with daily activities (shopping). Previously reported blood pressure on 27May2021 blood pressure 150/80 & today 128/82 improving. Missed doses due to receiving the COVID 19 vaccine (2 months ago) symptoms "sore arms" resolved, unknown if MD was aware. Tired from time to time unchanged (onset unknown). MD is pleased with recent blood work. On 27May2021, the patient underwent lab tests and procedures which included blood pressure measurement: 150/80 and on an unspecified date on 2021, blood pressure measurement: 128/82 (improving). Therapeutic measures were taken as a result of hypertension with lisinopril oral. On an unspecified date on 2021, the patient recovered from the event COVID vaccine / sore arm. The outcome of the event hypertension was recovering and for tired was unknown.  No follow-up attempts are needed, information about batch/lot number cannot be obtained.
Narrative: Patient received two doses of covid vaccine. Limited documentation avail in chart. Unclear PMH. No details of death. Reporting per facility instruction.
Chills, headache, body aches, nausea. Symptoms continued to get worse for 2 days. Went to ER where I was given IV fluids and anti-nausea meds. Feel much better following treatment.
Breakthrough case of COVID-19. I had a sore throat, congestion, cough and a migraine. I had some abdominal and muscle pain. About 6 days in I started having chest pain, brain fog, trouble breathing and some dizziness. I think that was it, I never had a significant fever. I had an elevated heart rate at 14 days in and that is when I went to see my doctor. I was given 7 days of a a steroid pack because I was still having elevated heat rate, trouble breath, dizziness and fatigue. I was still feeling pretty bad after that, and she gave me another 7 days of steroids and that seemed to help with the fatigue. I was probably not back to 100% until about 4 weeks later, I still had had trouble breathing and fatigue. My doctor ended up diagnosing me with post COVID-19 postural orthostatic tachycardia. My heart rate is elevated whenever I stand up.
This spontaneous report was received from a pharmacist and refers to a 20 year female patient. The patient had no pertinent medical history, no drug reactions and no allergies. On 27-JUL-2016, the pharmacist administered dose 2 of RECOMBIVAX HB strength 10/1.0 microgram/ml, 1 ml intramuscularly ( lot # L042846, expiration date 15-SEP-2017) to the patient. Immediately after administration, the patient fainted, while still at the pharmacy. The patient regained consciousness and her eyes were dilated. She also stated that her heart was "palpitating". The patient recovered from the events while she was still at the pharmacy and did not require any treatment. The patient said that she had not eaten all day prior to vaccination. The causality assessment between the events and RECOMIBVAX HB was not provided. Additional information has been requested.
Itching; It started getting red; Big rash looking around the injection area; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), VACCINATION SITE ERYTHEMA (It started getting red) and VACCINATION SITE RASH (Big rash looking around the injection area) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037V20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching), VACCINATION SITE ERYTHEMA (It started getting red) and VACCINATION SITE RASH (Big rash looking around the injection area). At the time of the report, PRURITUS (Itching) had resolved, VACCINATION SITE ERYTHEMA (It started getting red) was resolving and VACCINATION SITE RASH (Big rash looking around the injection area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that the rash started in a quarter size, and every day it got bigger and bigger and became almost 6" across. He saw it on TV news that it was called the COVID arm, which is a reaction to the injection. He put ice pack on it drank a lot of water. Concomitant medications were not provided.
Left arm pain, swelling, redness, erythema 6x4", Urticaria 2x1", fever, Ice, observation Keflex 500mg TID.
Patient received vaccine at 10:18am and then went home with no reaction in the vaccination POD. EMS was called to the patients home shortly before 2:30 that afternoon. When EMS arrived patient was posturing with lower extremities extended in plantar flexion. Last seen normal 30 minutes prior. she was also tachycardic and in respiratory distress with sonorous respirations. Cranial nerve deficit present GCS 3.She was unresponsive and intubated. Airlifted after CT to hospital. She died at 1647 at Hospital from hemorrhagic stroke.
severe arm pain for three days; fatigue; diarrhea for two days; headache; nauseous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 21Aug2021 (Lot number: fa7485) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Sensitive to gluten" (unspecified if ongoing); "covid" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Concomitant medication(s) included: VITAMINS C; VITAMIN D [VITAMIN D NOS]; ZINC. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered with sequelae", described as "severe arm pain for three days"; FATIGUE (non-serious), outcome "recovered with sequelae", described as "fatigue"; DIARRHOEA (non-serious), outcome "recovered with sequelae", described as "diarrhea for two days"; HEADACHE (non-serious), outcome "recovered with sequelae", described as "headache"; NAUSEA (non-serious), outcome "recovered with sequelae", described as "nauseous". The events "severe arm pain for three days", "fatigue", "diarrhea for two days", "headache" and "nauseous" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of pain in extremity, fatigue, diarrhoea, headache, nausea.  No follow-up attempts are possible. No further information is expected.
pt given first dose moderna vaccine  and within 15 minutes reported numbness of side of face and dizziness. pt given juice and water and sat for 45 minutes. pt symptoms stayed consistant, not getting worse but not better either. pt family came and pt left walking on her own to go to hospital and make sure everything is ok.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a female patient who received SHINGRIX (batch number 4492P, expiry date 30th April 2020) for prophylaxis. On 27th June 2018, the patient received SHINGRIX. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced injection site erythema, injection site pain and injection site swelling. On an unknown date, the outcome of the injection site erythema, injection site pain and injection site swelling were unknown. It was unknown if the reporter considered the injection site erythema, injection site pain and injection site swelling to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist stated that patient was administered SHINGRIX on Wednesday and returned to the pharmacy on the day of reporting and was still having redness and swelling at the injection site. The health care professional was asking if this was normal for these reactions to last 5 days. The patient also said that her arm where she was administered SHINGRIX bothered her when she was laying down on that arm and was painful. No further information was provided.
Patient given Kinrix instead of Prevnar 13 at time of vaccination on 10/21/22
Patient developed severe headache, vomiting, muscle aches, fever 9/17/07-records received for DOS 8/20-8/29/07- DC DX: Viral menigitis enterovirus. Presented with headache, nausea and emesis. Discharged after 4 day stay but on way out of hospital developed severe c/o and seen in ER for fever and headache. Received menigitis vaccine 48 hours prior to presenting to ER for first admission.  Follow-up: Patient had viral meningitis confirmed (enterovirus).